Skip to main content

PFIZER IRELAND PHARMACEUTICALS

PFIZER

How PFIZER IRELAND PHARMACEUTICALS appears in the EU Horizon funding graph: the research projects it has won money for, the consortia it joined, the EuroSciVoc topics it works in, and the organisations it co-funds projects with.

1 Horizon project, EUR 0 total EC contribution, last active 2031.

Organisation

Country
IE (IE053)
Organisation type
PRC
VAT number
IE9767830C
CORDIS match
high confidence

Horizon projects

EU Horizon research projects PFIZER IRELAND PHARMACEUTICALS participated in, with its role and the EC contribution recorded for this organisation. Figures cover EU Horizon grants only, not total EU spend.

Driving Sustainable Innovation to Minimise PFAS in European Healthcare (PFAROS)

associatedpartner

PFAROS is our European game-changing initiative to accelerate the transition away from harmful PFAS substances in the pharmaceutical and medical technology sectors. Aligned with EU public health, environmental, and industrial policy objectives, PFAROS is developing safe, scalable, and regulatory-ready alternatives, ensuring that healthcare innovation and sustainability go hand in hand. PFAROS’ mission is to replace PFAS in medical and pharmaceutical applications through a multidisciplinary approach, combining validated alternatives, advanced degradation and disposal technologies, and data science to support informed substitution and policy action. At the core of PFAROS is a policy-informed, AI-powered data tool that maps PFAS use, identifies viable alternatives, and integrates life-cycle, exposure, and toxicological data—empowering evidence-based policy and regulatory decisions. Coupled with broad stakeholder engagement and social science integration, the project ensures a just and informed transition. PFAROS will ultimately unlock a PFAS-free future for Europe’s healthcare system by: 1. Developing an integrated testing and assessment framework to implement the safe and sustainable by design approach for PFAS replacement; 2. Providing validated, industry-ready PFAS alternatives to ensure rapid adoption; 3. Enabling data-driven decision-making through a PFAROS AI-powered data tool tailored to support regulatory needs; 4. Setting the gold standard for sustainable alternatives and end-of-life solutions in critical applications; 5. Ensuring broad adoption and fostering cross-sector collaboration with industry, regulators, academia, and civil society; 6. Positioning the EU as a global leader in sustainable chemical policy and healthcare innovation. PFAROS is more than a scientific initiative—it is a policy enabler, offering concrete tools and solutions to support a safer, greener, and more resilient healthcare system for Europe. The PFAROS project is a public private partnership (IHI).

EC contribution:
EUR 0
Start:
2026-09-01
End:
2031-08-31
Status:
SIGNED
Scheme:
HORIZON-JU-RIA
Call:
HORIZON-JU-IHI-2025-10-two-stage
data sciencepublic healthcivil society

View on CORDIS (DOI 10.3030/101251281)

Co-funding partners

Organisations that PFIZER IRELAND PHARMACEUTICALS has shared one or more EU Horizon projects with, ranked by the number of shared projects. 1 of these are Irish organisations with their own profile.

TECHNOLOGIE SERVIER
1 shared project
Merck S.L.U.
1 shared project
Boehringer Ingelheim Corporate Center GmbH
1 shared project
TERUMO EUROPE
1 shared project
OLYMPUS WINTER & IBE GMBH
1 shared project
TERUMO DENMARK, FILIAL AF TERUMO SWEDEN AB
1 shared project
Terumo Sweden AB
1 shared project
Terumo France SAS
1 shared project
ElringKlinger Kunststofftechnik GmbH
1 shared project
Sanofi US Services Inc.
1 shared project
Medical Devices & Diagnostics Global Services, LLC
1 shared project
Pfizer Healthcare India Private Limited
1 shared project
Bayer Consumer Care AG
1 shared project
ORIL INDUSTRIE
1 shared project
SANOFI WINTHROP INDUSTRIE
1 shared project
NORGES GEOTEKNISKE INSTITUTT AS
1 shared project
Merck Santé S.A.S.
1 shared project
MERCK LIFE SCIENCE KGAA
1 shared project
EDWARDS LIFESCIENCES LLC
1 shared project
Pfizer R&D UK Limited
1 shared project
BAYER HEALTHCARE LLC
1 shared project
EDWARDS LIFESCIENCES BV
1 shared project
Lilly Deutschland GmbH
1 shared project
Johnson & Johnson Services, Inc.
1 shared project
MEDICAL DEVICE BUSINESS SERVICES INC
1 shared project
EDWARDS LIFESCIENCES GMBH
1 shared project
EDWARDS LIFESCIENCES SL
1 shared project
EDWARDS LIFESCIENCES BELGIUM BV
1 shared project
ELI LILLY AND COMPANY
1 shared project
PFIZER INC
1 shared project

Showing the top 30 of 88 co-funding partners by shared-project count.

Research topics

civil societydata sciencepublic health

TenderWatch Pro

See which contracts are expiring soon and get matched to re-tenders

Unlock the full Contract Expiry Radar, unlimited Tender Matcher runs, competitor award watching, and CSV exports across every authority and supplier. EUR 49 a month, cancel any time.

See TenderWatch Pro

About this data

This profile is built from the European Commission CORDIS open dataset of EU Horizon research projects, covering the digital and AI research vertical. It records EU Horizon grant participation only and does not represent an organisation's total EU funding. Verify figures against the official record before relying on them.

Source: CORDIS (CC-BY-4.0), snapshot 2026-10-04.cordis.europa.eu

Back to the Irish consortium graphPublic grant awards database →